The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Based on the BioMark Diagnostics Inc stock forecast from 0 analysts, the average analyst target price for BioMark Diagnostics Inc is not available over the next 12 months. BioMark Diagnostics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BioMark Diagnostics Inc is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, BioMark Diagnostics Inc’s stock price was USD 0.1839. BioMark Diagnostics Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -3.16% over the last year.
No recent analyst target price found for BioMark Diagnostics Inc
No recent average analyst rating found for BioMark Diagnostics Inc
Company Overview BioMark Diagnostics Inc
Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It holds an agreement with National Research Council of Canada Industrial Research Assistance Program to support research and development of liquid biopsy assay for the early detection and screening of lung cancer; and strategic partnership with Rubix LS to develop diagnostic tools to enhance lung cancer screening and improve breast cancer screening program for women with dense breasts. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc. Read Less
Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It holds an agreement with National Research Council of Canada Industrial Research Assistance Program to support research and development of...Read More
Frequently Asked Questions About BioMark Diagnostics Inc (BMKDF) Stock
Stock Target Advisor's fundamental analysis for BioMark Diagnostics Inc's stock is Bearish.
Unfortunately we do not have enough data on BMKDF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BMKDF's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on BMKDF's stock to indicate if its overvalued.
The last closing price of BMKDF's stock was USD 0.18.
The most recent market capitalization for BMKDF is USD 0.02B.
Unfortunately we do not have enough analyst data on BMKDF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains BioMark Diagnostics Inc's stock.
As per our most recent records BioMark Diagnostics Inc has 0 Employees.
BioMark Diagnostics Inc's registered address is 3851 Shell Road, Richmond, BC, Canada, V6X 2W2.
You can get more information about it from BioMark Diagnostics Inc's website at https://www.biomarkdiagnostics.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BMKDF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
